Additionally, the incidence of Klrk1+/+mice developing tumours with the highest IHC score (score 3) was mildly increased compared with Klrk1−/−mice (19% versus 11.1% for GS; 9.6% versus 3.7% for Glypican-3 and 19% versus 11.1% for HSP70 respectively) (Supplementary Table 1; Supplementary Fig. 1c,f,i). The gene discussed is KLRK1; the disease is neoplasm.